Previous 10 | Next 10 |
Small-cap rad-onc company ViewRay ( VRAY ) certainly doesn't lack for ambition, as it is trying to disrupt the $5 billion radiation oncology equipment market with its MRI-guided MRIdian system. While ViewRay brings a lot of positives to the table that should presage meaningful market growth,...
CLEVELAND , Dec. 19, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Sparrow Health System in Lansing, Michigan has begun patient treatments with MRIdian® Linac, a cutting-edge radiation therapy system that combines the latest innovations in precision ra...
CLEVELAND , Dec. 17, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that the first MRIdian MRI-guided radiotherapy system in the United Kingdom (UK) – located at GenesisCare Oxford – has begun patient treatments. MRIdian combines high definition MRI...
InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...
Larry Culp is a Builder of Corporations, Not a Caretaker We've all heard the nostrum "The best defense is a good offense". The best way for General Electric (GE) to dig out of its liabilities is to change the growth profile and boost cash flow. The opportunity to gather revenue-generating ...
CNS Pharmaceuticals (NASDAQ: CNSP ) initiated with Speculative Buy rating at Benchmark. More news on: CNS Pharmaceuticals, Inc., Proteostasis Therapeutics, Inc., STAAR Surgical Company, Healthcare stocks news, Stocks on the move, , Read more ...
ViewRay (NASDAQ: VRAY ) has priced its public offering of 41,550,000 common shares at $3.13 per share, for gross proceeds of ~$130.1M. More news on: ViewRay, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Tuesday was a bad day on Wall Street, as major benchmarks fell sharply on news from the White House regarding trade. President Trump said that it might be better for the U.S. not to expect a trade deal with China until after the 2020 presidential election, throwing cold water on recent hopes tha...
Gainers: Audentes Therapeutics (NASDAQ: BOLD ) +105% . More news on: Audentes Therapeutics, Inc., ViewRay, Inc., Outlook Therapeutics, Inc., Stocks on the move, Read more ...
In response to announcing collaboration deals with Elekta and Medtronic (NYSE: MDT) as well as a common stock offering, shares of ViewRay (NASDAQ: VRAY) , a seller of innovative radiation therapy machines, jumped 31% as of 11:15 a.m. EST on Tuesday. Here are the key terms of the dea...
News, Short Squeeze, Breakout and More Instantly...
ViewRay® Announces Commencement of Nasdaq Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Markets PR Newswire DENVER , July 21, 2023 /PRNewswire/ -- ViewRay, Inc. (the "Company") (Nasdaq: VRAY) announced today that on July 17 , i...